Peter Aaby

Source: Wikipedia, the free encyclopedia.
Peter Aaby
Born (1944-11-06) 6 November 1944 (age 79)
CitizenshipDanish
Alma materUniversity of Copenhagen
Known forNon-specific effects of vaccines
AwardsNovo Nordisk Prize (2000)
Scientific career
FieldsHealth, epidemiology
InstitutionsBandim Health Project

Peter Aaby (

doctoral degree in medicine.[1] In 1978, Peter Aaby established the Bandim Health Project, a Health and Demographic Surveillance System site in Guinea-Bissau in West Africa, which he has run ever since.[2] In 2000, Peter Aaby was awarded the Novo Nordisk Prize, the most important Danish award within health research
.

Aaby is credited for the discovery of

WHO recently reviewed the evidence for non-specific effects of BCG vaccine, measles vaccine and DTP vaccine, and concluded that it would "keep a watch on the evidence of nonspecific effects of vaccination".[6]

See also

References

  1. .
  2. ^ "Background". Bandim Health Project. SSI. Retrieved 28 September 2015.
  3. PMID 19174540
    .
  4. .
  5. .
  6. .

External links